Lunch Activity/Non-CE Accredited Satellite Symposium: The Facts on the Combined Power of RYBREVANT® + LAZCLUZE for the First-Line Treatment of EGFR+ Locally Advanced or mNSCLC
Johnson & Johnson
Seating is available on a first-come, first-served basis.